Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance. | Drug Resist Updat | 2024 | 37980859 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 1, a major regulator of biological processes. | Biochem Cell Biol | 2024 | 37922507 | PubTator, text mining | PubMed |
| Blood DNA methylation signature of diet quality and association with cardiometabolic traits. | Eur J Prev Cardiol | 2024 | 37793095 | PubTator, text mining | PubMed |
| Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation. | J Biochem Mol Toxicol | 2024 | 37700640 | PubTator, text mining | PubMed |
| Targeted nanopore sequencing for the identification of novel PRMT1 circRNAs unveils a diverse transcriptional profile of this gene in breast cancer cells. | Genes Dis | 2024 | 37692475 | PubTator, text mining | PubMed |
| Clinical analysis of Gabriele-de Vries caused by YY1 mutations and literature review. | Mol Genet Genomic Med | 2024 | 37658636 | PubTator, text mining | PubMed |
| Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer. | Genes Dis | 2024 | 37588202 | PubTator, text mining | PubMed |
| Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action. | Cancers (Basel) | 2023 | 38201512 | PubTator, text mining | PubMed |
| Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis. | Front Microbiol | 2023 | 38188582 | PubTator, text mining | PubMed |
| Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA. | Viruses | 2023 | 38140556 | PubTator, text mining | PubMed |
| A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy. | Biomolecules | 2023 | 38136558 | PubTator, text mining | PubMed |
| PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma. | Cancers (Basel) | 2023 | 38136401 | PubTator, text mining | PubMed |
| Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 38136342 | PubTator, text mining | PubMed |
| Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells. | PLoS One | 2023 | 38134182 | PubTator, text mining | PubMed |
| Carcinogenesis and Prognostic Utility of Arginine Methylation-Related Genes in Hepatocellular Cancer. | Curr Issues Mol Biol | 2023 | 38132437 | PubTator, text mining | PubMed |
| Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression. | Biology (Basel) | 2023 | 38132337 | PubTator, text mining | PubMed |
Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma. | Heliyon | 2023 | 38125466 | PubTator, text mining | PubMed |
| PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. | Cell Rep Med | 2023 | 38118413 | PubTator, text mining | PubMed |
| Ferritinophagy: research advance and clinical significance in cancers. | Cell Death Discov | 2023 | 38110359 | PubTator, text mining | PubMed |
| Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance. | Front Genet | 2023 | 38075690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=13